Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Roy, Souvik
- Current Havoc of TB and its Alleviation by Green Pharmacy Discipline : Medical Biotechnology
Abstract Views :424 |
PDF Views:3
Authors
Affiliations
1 Post-Graduate Department of Biotechnology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, IN
2 Department of Microbiology, Lady Brabourne College, P-1/2, Suhrawardy Avenue, Kolkata-700 017, West Bengal, IN
1 Post-Graduate Department of Biotechnology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, IN
2 Department of Microbiology, Lady Brabourne College, P-1/2, Suhrawardy Avenue, Kolkata-700 017, West Bengal, IN
Source
Indian Science Cruiser, Vol 31, No 3 (2017), Pagination: 43-49Abstract
Tuberculosis (TB) remains one of the deadliest diseases of humans, with a present worldwide annual mortality rate of over a million. Global resurgence of TB, and the emergence of multi-drug resistant TB (MDR-TB) and extensively-drug resistant TB (XDR-TB) in India call for the development of new anti-tubercular drugs to combat them. Medicinal plants from the rich heritage of Indian flora, a lesser-explored area as anti-TB green pharmacy till date, offer a hope for the development of alternative medicines, necessitating their potencies to be meticulously scanned and evaluated. For the effective control of MDR-strains of Mycobacterium tuberculosis, a systematic screening of plants would be the first step in the development of a suitable phytodrug, which would also be economically viable in the medicinal plant trade. Use of such non-conventional anti-TB herbal medicines is expected to acquire brisk popularity, owing to the toxicity and overwhelming side-effects of anti-tubercular allopathic medicines. In the present review, a situation report on the on-going global efforts to discover and develop drugs from twelve selected medicinal plants have been discussed, which have ample potential as anti-TB agents, as identified from various sources in the corresponding literature reviewed.Keywords
Tuberculosis, Multi-drug Resistant TB (MDR-TB), Extensively-drug Resistant Tb (XDR-TB), Anti-tubercular Drugs, Green Pharmacy, Alternative Medicines, Phytodrug, Medicinal Plant Trade, Anti-tb Herbal Medicines.
References
- World Health Organization (WHO). Global tuberculosis report 2016. 2016. http://apps.who.int/iris/bitstre am/10665/250441/1/9789241565394-eng.pdf?ua=1. Accessed 4 May, 2017.
- Central TB Division, Directorate General of Health Sciences, Ministry of Health & Family Welfare, Govt. of India. TB India 2015 Revised National TB Control Programme Annual Status Report, New Delhi. 2015.http://www.tbcindia.nic.in/index1.php?lan g=1&level=1&sublinkid=4737&lid=3275. Accessed 10 May, 2017.
- Global tuberculosis control: WHO report 2011. 2011. http://apps.who.int/iris/ bitstream/10665/44728/1/97892 41564380_ eng.pdf. Accessed 27 February, 2016.
- World Health Organization (WHO). Global tuberculosis report 2013. 2013. http:// who.int/tb/publications/global_report/en/.Accessed 10 April, 2014.
- Lawn SD, and Zumla AI. Tuberculosis. Lancet. 2011; 378(9785):57-72.
- Wikipedia, (2017), “Standard of Living in India.” Web. http://en.wikipedia.org/wiki/ Standard_of_living_in_India. Accessed 4 May, 2017.
- The Times of India Kolkata, (2003), “TB rates high in Bengal: WHO.” Web. http://timesofindia.indiatimes.com/city/ kolkata/TB-rates-high-in-Bengal-WHO/ articleshow/41308700.cms. Accessed 16 October, 2014.
- N. N. Ibekwe, and S. J. Ameh, Plant natural product research on tuberculosis drug discovery and development: A situation report with focus on Nigerian biodiversity. Afr J Biotechnol. 2014; 13(23):2307-2320.
- World Health Organization (WHO). Global tuberculosis report 2015. 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789 241565059_eng.pdf. Accessed 27 February, 2016.
- A. Vikrant, A Review on Anti-Tubercular Plants. Int J PharmTech Res. 2011; 3(2):872880.
- MI. Shareef Chapter 1. pdf - Shodhganga.http://shodhganga.inflibnet.ac.in/ bitstream/10603/37093 /5/chapter%201.pdf. 2015. Accessed 30 January, 2016.
- TH Yu, CM. Wu Stability of allicin in garlic juice. J Food Sci. 1989; 54:977-981.
- S. Ankri, and D. Mirelman, Antimicrobial properties of allicin from garlic. Microb Infect. 1999; 1:125–129.
- S. Roy, and A. Nag Chaudhuri, Bactericidal Effect of Garlic Extract on Mycobacterium smegmatis. International Journal of Scientific Research. 2015; 4(3):1-6.
- S. Roy, and A. Nag Chaudhuri, Changes in signal cross-talking in Mycobacterium smegmatis infected murine macrophages in presence of aqueous garlic extract. International Journal of Applied Research. 2016; 2(5):810-816.
- D. G. Sheeba, K. S. Gomathi, and T. Citarasu, Anti-Mycobacterial and Phytochemical Investigation of Methanol Extracts of few Medicinal Plants. Journal of Chemical and Pharmaceutical Sciences. 2015; 8(3).
- R. Kaur, and H. Kaur, Antitubercular Activity and Phytochemical Screening of Selected Medicinal Plants. Orient J Chem. 2015; 31(1):597-600.
- S. Suhitha, S. K. Devi, K. Gunasekaran, H. C. Pakyntein, A. Bhattacharjee, and D.Velmurugan, Phytochemical Analyses and Activity of Herbal Medicinal Plants of NorthEast India for Anti-Diabetic, Anti-Cancer and Anti-Tuberculosis and their Docking Studies. Current Topics in Medicinal Chemistry. 2015; 15(1):21-23.
- Bacteria –The New ‘magic Bullet’ Against Cancer!
Abstract Views :521 |
PDF Views:5
Authors
Affiliations
1 Department of Biotechnology
2 Department of Microbiology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, IN
1 Department of Biotechnology
2 Department of Microbiology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, IN
Source
Indian Science Cruiser, Vol 32, No 6 (2018), Pagination: 25-31Abstract
Microbes in general, as also the commensal human microbiota, are an important modulator of disease physiology of the host, including affecting cancer proliferation and progression. Cancer metastasis still remains an enigma in origin and consequence, and is one of the most important causes of morbidity and mortality of man in the recent times. A myriad of beneficial immunological effects, including the highly important anti-cancer activities, have been attributed to some specific bacteria, as also some members of the human normal microflora. Even though there is no direct experimental evidence as of now, in support of cancer suppression as a result of microbial infestation in the human body, yet, there is a wealth of indirect evidence available in the literature, which is based largely on laboratory studies, and those will grossly be revisited in the present paper. As bacteria-mediated tumour therapy (BMTT) has ample potential to evolve into the much desired ‘magic bullet’ against various types of malignancies, this paper aims to present a state-of-the-art review on applicability of bacteria as cancer therapeutics. Further, this review will delineate the selective advantages of BMTT over the conventional chemotherapeutic drugs against cancer, and will also discuss the associated challenges ahead.Keywords
Commensal Human Microbiota, Cancer Metastasis, BMTT, Magic Bullet, Malignancies, Cancer Therapeutics.References
- R. Koch UntersuchungenüberBakterien: V. Die Atiologie der Milzbrand-Krankheit, begründet auf die Entwicklungsgeschichte des Bacillus anthracis. CohnsBeitragezurBiologie der Pflanzen. 1876; 2(2):277-310.
- DJ. Grimes Koch’s Postulates—Then and Now. Microbe. 2006; 1(5):223-228.
- RA. Weinberg Biology of Cancer, 2nd Edition (Garland Science). 2007.
- J. Parsonnet Bacterial Infection as a Cause of Cancer. Environ Health Perspect. 1995; 103:263-268.
- E. Velazqueza A. Peixb, and A. Gomez-Alonso Microorganisms and cancer: Scientific evidence and new hypotheses. Cirugía Española (English Edition). 2011; 89(3):136-144.
- S Felgner, D Kocijancic, M Frahm, and S. Weiss Bacteria in Cancer Therapy: Renaissance of an Old Concept. Int J Microbiol. 2016; 8451728.
- S Felgner, V Pawar, D Kocijancic, M Erhardt, and Weiss S.Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome. Microb Biotechnol. 2017; 10(5):1074-1078.
- B Umer, D Good, J Anné, W Duan, and Wei MQ. Clostridial spores for cancer therapy: targeting solid tumour microenvironment. J Toxicol. 2012; 862764.
- S Liu, X Xu, X Zeng, L Li, Q Chen, and J. Li Tumor‑targeting bacterial therapy: A potential treatment for oral cancer (Review). Oncol Lett. 2014; 8:2359-2366.
- G Housman, S Byler, S Heerboth, K Lapinska, M Longacre, N Snyder and S. Sarkar Drug resistance in cancer: an overview. Cancers (Basel). 2014; 6(3):1769-1792.
- FJ. Esteva Monoclonal Antibodies, Small Molecules, and Vaccines in the Treatment of Breast Cancer. The Oncologist. 2004; 9.
- B Alberts, A Johnson, J Lewis, D Morgan, M Raff, K Roberts, and P. Walter Molecular Biology of the Cell, 6th Edition (Garland Science). 2015.
- F Sabzehali, H Azimi, and M. Goudarzi Bacteria as a vehicle in cancer therapy and drug delivery. J Paramed Sci. 2017; 8(1).
- S Bashiardes, T Tuganbaev, S Federici and E. Elinav The microbiome in anti-cancer therapy. Semin Immunol. 2017; 32:74-81.
- NS Forbes Profile of a bacterial tumor killer. Nat Biotechnol. 2006; 24:1484‑1485.
- HC Nauts, WE Swift, and BL Coley. The Treatment of Malignant Tumors by Bacterial Toxins as Developed by the Late William B. Coley, M.D., Reviewed in the Light of Modern Research. Cancer Res. 1946; 6:205-216.
- M Sznol, L. Stanley Lin, David Bermudes, Li-mou Zheng, and I. King Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest. 2000; 105(8):1027–1030.
- LH Dang, C Bettegowda, DL Huso, KW Kinzler and B. Vogelstein Combination bacteriolytic therapy for the treatment of experimental tumors. PNAS. 2001; 98(26):15155-15160.
- CA Hunter, D Yu, M Gee, CV Ngo, C Sevignani, M Goldschmidt, TV Golovkina, S Evans, WF Lee and A. Thomas-Tikhonenko Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis. J Immunol. 2001; 166(10):5878-5881.
- A Darzins, and AM. Chakrabarty Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol. 1984; 159(1):9-18.
- T Yamada, M Goto, V Punj, O Zaborina, ML Chen, K Kimbara, D Majumdar, E Cunningham, TK Das Gupta, and AM. Chakrabarty Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. PNAS. 2002; 99(22):14098-14103.
- T Yamada, Y Hiraoka, M Ikehata, K Kimbara, BS Avner, TK Das Gupta, and AM Chakrabarty. Apoptosis or growth arrest: Modulation of tumor suppressor p53’s specificity by bacterial redox protein azurin. PNAS. 2004; 101(14):4770-4775.
- P Chorobik, D Czaplicki, K Ossysek, and J. Bereta Salmonella and cancer: from pathogens to therapeutics. ActaBiochim Pol. 2013; 60(3):285–297.
- JH Zheng, VH Nguyen, S-N Jiang, S-H Park, W Tan, SH Hong, MG Shin, IJ Chung et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017; 9(376):1-10.
- A Sivan, L Corrales, N Hubert, JB Williams, K Aquino-Michaels, ZM Earley, FW Benyamin, YM Lei, B Jabri, M-L Alegre, EB Chang and TB Gajewski. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science. 2005; 350(6264):1084-1089.
- RD Lardone, AA Chan, AF Lee, LJ Foshag, MB Faries, PA Sieling and DJ. Lee Mycobacterium bovis Bacillus Calmette–Guerin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function. Front Immunol. 2017; 8:965.
- M Tangney and CGM. Gahan Listeria monocytogenes as a Vector for Anti-Cancer Therapies. Curr Gene Ther. 2010; 10(1):46-55.
- L Zhong, X Zhang, and M. Covasa Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014; 20(24):7878-7886.
- K Hirayama and J. Rafter The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000; 2(6):681-686.
- BL Pool-Zobel, C Neudecker, I Domizlaff, S Ji, U Schillinger, C Rumney, M Moretti, I Vilarini, R Scassellati-Sforzolini and I. Rowland Lactobacillus-and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer. 1996; 26(3):365-380.
- S Patyar, R Joshi, DS Byrav, A Prakash, B Medhi, and BK. Das Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci. 2010; 17(1):21.
- L Sanchez-Garcia, L Martín, M Ramon, Neus Ferrer-Miralles, V Esther and V. Antonio Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb Cell Fact. 2015; 15:33.
- S Geisse, H Gram, B Kleuser, and HP. Kocher Eukaryotic Expression Systems: A Comparison. Prot. Expr. Purif. 1996; 8(3):271-282.
- R Mercado-Lubo, Y Zhang, L Zhao, K Rossi, X Wu, Y Zou, A Castillo, J Leonard, R Bortell, DL Greiner, LD Shultz, G Han and BA. McCormick A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours. Nat Commun. 2016; 7:12225.
- T Danino, A Prindle, GA Kwong, M Skalak, H Li, K Allen, J Hasty and SN. Bhatia Programmable probiotics for detection of cancer in urine. Sci Transl Med. 2015; 7(289):289.
- Yu YA, S Shabahang, TM Timiryasova, Q Zhang, R Beltz, I Gentschev et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol. 2004; 22:313–320.